June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Effect of an Intravitreal Anti-VEGF Injection on the Dynamics of the Anterior Segment
Author Affiliations & Notes
  • Jonathan Naysan
    Ophthalmology, North Shore - Long Island Jewish, Great Neck, NY
  • Tushar Suthar
    Ophthalmology, North Shore - Long Island Jewish, Great Neck, NY
  • Ronni Lieberman
    Ophthalmology, Mount Sinai University Medical Center, New York, NY
  • Jonathan Jonisch
    Ophthalmology, North Shore - Long Island Jewish, Great Neck, NY
    Ophthalmology, Long Island Vitreoretinal Consultants, Great Neck, NY
  • Footnotes
    Commercial Relationships Jonathan Naysan, None; Tushar Suthar, None; Ronni Lieberman, None; Jonathan Jonisch, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 6302. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jonathan Naysan, Tushar Suthar, Ronni Lieberman, Jonathan Jonisch; Effect of an Intravitreal Anti-VEGF Injection on the Dynamics of the Anterior Segment. Invest. Ophthalmol. Vis. Sci. 2013;54(15):6302.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Intravitreal injections of various pharmacologic agents are now standard of care in a number of retinal vascular diseases. Optical Coherence Tomography (OCT) allows imaging of the anterior segment, specifically the angle structures, anterior chamber, and cornea. This study investigates the effects of a single intravitreal anti-VEGF injection on the dynamics of the anterior segment structures.

Methods: A chart review was done looking for patients who had received a single intravitreal injection of either Lucentis ® (ranibizumab), Avastin ® (bevacizumab), or Eylea ® (aflibercept), in addition to anterior segment imaging of the same eye. Nine eyes were identified. Each eye was injected with equal volumes (0.05mL). Using the Visante Optical Coherence Tomography (OCT) machine, imaging of the anterior segment was performed 5 minutes before and after the injection. The angle opening distance (AOD) and trabeculo-iris space area (TISA) at 500µm and 750µm anterior to the scleral spur were measured both pre and post injection. The scleral spur angle (SSA), and central corneal thickness (CCT) were also obtained. None of the patients carried the diagnosis of glaucoma or anterior segment anomalies.

Results: Of the 9 patients, 7 were injected into the left eye and 2 in the right. Six were injected with Lucentis, 2 with Avastin, and 1 with Eylea. The mean pre injection AOD(500µm) was 0.385mm and post injection 0.369mm with a mean difference of -0.0165mm (-4.2%, p=0.19) after injection. The mean pre injection AOD(750µm) was 0.542mm and post injection 0.536mm with a mean difference of -0.0064mm (-1.2%, p=0.35). The TISA(500µm) mean pre injection was 0.145mm2 and post injection was 0.133mm2 with a mean difference of -0.012mm2 (-8.3%, p=0.029). The TISA(750µm) mean pre injection was 0.26mm2 and post injection was 0.133mm2 with a mean difference of -0.13mm2 (-49%, p< 0.001). The SSA decreased by an average of 2.2% (p=0.28). The CCT showed a 0.2% increase after injection (p=0.32).

Conclusions: A statistically significant decrease in the TISA at both 500µm and 750µm after an anti-VEGF intravitreal injection is seen. While the AOD and SSA both decreased overall, they did not reach statistical significance. Intravitreal injections may have an effect on the dynamics of the anterior segment, specifically the angle structures. Further studies are warranted on the effects of intravitreal injections on the angle dynamics.

Keywords: 561 injection • 421 anterior segment • 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound)  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×